Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for shares of Tango Therapeutics in a research report issued to clients and investors on Monday, March 10th. Cantor Fitzgerald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback